Licensing and Prescribing Biosimilars in Australia

GaBI Journal - Belgium
doi 10.5639/gabij.2013.0203.030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pro Pharma Communications International

Related search

Licensing of Mifepristone in New Zealand and Australia

Journal of Family Planning and Reproductive Health Care
2012English

Evaluation of Physicians’ Knowledge and Attitudes Towards Biosimilars in Russia and Issues Associated With Their Prescribing

Biomolecules
BiochemistryMolecular Biology
2019English

State-Based Business Licensing in Australia: The Constitution, Economics and International Perspectives

Deakin Law Review
2009English

Biosimilars in Medicine

Era's journal of medical research
2017English

Biosimilars

ESMO Open
Cancer ResearchOncology
2018English

Biosimilars: Approval and Acceptance?

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Biosimilars 2.0

mAbs
AllergyImmunology
2011English

Community-Based Prescribing for Impetigo in Remote Australia: An Opportunity for Antimicrobial Stewardship

Frontiers in Public Health
EnvironmentalPublic HealthOccupational Health
2017English

Social Prescribing as an Intervention for People With Work-Related Injuries and Psychosocial Difficulties in Australia

Advances in Health and Behavior
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy